Dawson James Reiterates BioCardiAa (BCDA) at Buy on Canada Expansion, Maintains $4 Price Target
Tweet Send to a Friend
Dawson James analyst Jason Kolbert reiterated a Buy rating and $4.00 price target on BioCardiAa (NASDAQ: BCDA), as the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
